Table 1.
The thrombolytic drugs data: entries are numbers of deaths in 30 or 35 days/number of patients. Bold entries show designs where inconsistency parameters are introduced (see text)
| Design d | Study | Streptokinase (A) | Accelerated alteplase (B) | Alteplase (C) | Streptokinase + alteplase (D) | Tenecteplase (E) | Reteplase (F) | Urokinase (G) | Anti-streptilase (H) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1462/20 173 | 652/10 344 | 723/10 328 | |||||
| 2 | 2 | 1455/13 780 | 1,418/13 746 | 1448/13 773 | |||||
| 3 | 3 | 9/130 | 6/123 | ||||||
| 4 | 5/63 | 2/59 | |||||||
| 5 | 3/65 | 3/64 | |||||||
| 6 | 887/10 396 | 929/10 372 | |||||||
| 7 | 7/85 | 4/86 | |||||||
| 8 | 12/147 | 7/143 | |||||||
| 9 | 10/135 | 5/135 | |||||||
| 4 | 10 | 4/107 | 6/109 | ||||||
| 5 | 11 | 285/2992 | 270/2994 | ||||||
| 6 | 12 | 10/203 | 7/198 | ||||||
| 7 | 13 | 3/58 | 2/52 | ||||||
| 14 | 3/86 | 6/89 | |||||||
| 15 | 3/58 | 2/58 | |||||||
| 16 | 13/182 | 11/188 | |||||||
| 8 | 17 | 522/8488 | 523/8461 | ||||||
| 9 | 18 | 356/4921 | 757/10 138 | ||||||
| 19 | 13/155 | 7/169 | |||||||
| 10 | 20 | 2/26 | 7/54 | ||||||
| 21 | 12/268 | 16/350 | |||||||
| 11 | 22 | 5/210 | 17/211 | ||||||
| 23 | 3/138 | 13/147 | |||||||
| 12 | 24 | 8/132 | 4/66 | ||||||
| 25 | 10/164 | 6/166 | |||||||
| 26 | 6/124 | 5/121 | |||||||
| 13 | 27 | 13/164 | 10/161 | ||||||
| 28 | 7/93 | 5/90 |